Novel human coronavirus infection: Difference between revisions
m Changes made per Mahshid's request |
|||
| Line 57: | Line 57: | ||
{{WS}} | {{WS}} | ||
[[category:disease]] | [[category:disease]] | ||
[[category:virology]] | [[category:virology]] | ||
Latest revision as of 18:13, 18 September 2017
| Coronavirus | ||||||||
|---|---|---|---|---|---|---|---|---|
 | ||||||||
| Virus classification | ||||||||
|
|
Novel Human Coronavirus Infection Microchapters |
|
Differentiating Novel Human Coronavirus Infection from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Novel human coronavirus infection On the Web |
|
American Roentgen Ray Society Images of Novel human coronavirus infection |
|
Directions to Hospitals Treating Novel human coronavirus infection |
|
Risk calculators and risk factors for Novel human coronavirus infection |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Synonyms and keywords: Human betacoronavirus 2c EMC/2012; novel coronavirus
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Case Definitions | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies